Akèy › Gliyòm › Texas › Houston
Etid klinik pou Gliyòm nan Houston, TX
23 etid pou Gliyòm ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Ap rekriteFaz 1/2
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
- UT MD Anderson Cancer Center, Houston
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Ap rekriteFaz 1/2
- Baylor College of Medicine, Houston
MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
Ap rekriteFaz 1
- M D Anderson Cancer Center, Houston
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
Ap rekriteFaz 2
- Texas Children's Hospital, Houston
MRE Scan for the Assessment of Differences in Tissue Stiffness Between Radiation Necrosis and Recurrent Glioma in Patients With Previously Treated Gliomas
Ap rekrite
- M D Anderson Cancer Center, Houston
Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma
Ap rekriteEtid obsèvasyon
- M D Anderson Cancer Center, Houston
Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation
Ap rekriteFaz 1
- The University of Texas M. D. Anderson Cancer Center, Houston
Targeted Pediatric High-Grade Glioma Therapy
Ap rekriteEtid obsèvasyon
- Texas Children's Hospital, Houston
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Ap rekriteFaz 1
- MD Anderson Cancer Center, Houston
Study of Olutasidenib and Temozolomide in HGG
Ap rekriteFaz 2
- Texas Children's Hospital, Houston
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Ap rekriteFaz 3
- MD Anderson Cancer Center, Houston
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
Ap rekriteFaz 2
- Texas Children's Hospital, Houston
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
Ap rekriteEtid obsèvasyon
- M D Anderson Cancer Center, Houston
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Ap rekriteFaz 1/2
- Research Site, Houston
Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)
Ap rekriteFaz 1
- Excel Diagnostics & Nuclear Oncology Center, Houston
C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
Ap rekriteFaz 1
- Texas Children's Hospital, Houston
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Ap rekriteFaz 2
- University of Texas MD Anderson Cancer Center, Houston
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Ap rekriteFaz 1 bonèVolontè an sante akeyi
- Texas Children's Hospital, Houston
Window-of-Opportunity Trial of Ulixertinib for MAPK-Activated Gliomas
Ap rekriteFaz 1 bonè
- M D Anderson Cancer Center, Houston
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Ap rekriteFaz 2
- Texas Children's Hospital, Houston
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Ap rekriteFaz 1
- MD Anderson Cancer Center, Houston
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Ap rekriteFaz 1/2
- MD Anderson Cancer Center, Houston
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
Ap rekriteFaz 1 bonè
- Texas Children's Hospital, Houston
Etid Gliyòm nan lòt vil
- New York City, NY25 etid
- Boston, MA20 etid
- Washington, DC19 etid
- Philadelphia, PA16 etid
- Miami, FL15 etid
- Columbus, OH15 etid
- San Francisco, CA14 etid
- Chicago, IL13 etid
- Durham, NC12 etid
- Seattle, WA11 etid
- Los Angeles, CA10 etid
- St. Louis, MO10 etid
Lòt etid nan Houston
- Kansè Poumon ki pa ti selil145 etid
- Kansè nan tete126 etid
- Kansè (tout kalite)121 etid
- Kansè Metastatik104 etid
- Kansè kolorektal102 etid
- Kansè ovè89 etid
- Leksemi mieloïd egi85 etid
- Kansè poumon78 etid
- Kansè pwostat76 etid
- Kansè Endomèt68 etid
- Kansè pankreyas61 etid
- Melanom59 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.